Synthesis of 10b(R)-hydroxypancratistatin, 10b(S)-hydroxy-1-epipancratistatin, 10b(S)-hydroxy-1,2-diepipancratistatin and related isocarbostyrils

George Pettit, Noeleen Melody, Delbert L. Herald, Jean M. Schmidt, Robin Pettit, Jean Chapuis

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Narciclasine (2) was transformed by a series of reactions where Sharpless asymmetric hydroxylations served as the stereochemical controlling step to 10b(R)-hydroxypancratistatin (3), 10b(S)-hydroxy-1-epipancratistatin (13) and 10b(S)-hydroxy-1,2-diepipancratistatin (16). Synthesis of 10b(S)-hydroxy-1,2-diepipancratistatin (16) proceeded from α-triol (11) via cyclic sulfate (14) and inversion of C-2 with cesium benzoate followed by saponification and treatment with a catalytic amount of acid. Compared to pancratistatin (1), these structural modifications led to decreased cancer cell growth inhibition against a minipanel of human cancer cell lines. Narciclasine (2) inhibited the pathogenic yeast Cryptococcus neoformans, and modifications (4, 14 and 15) inhibited growth of the pathogenic bacterium Neisseria gonorrhoeae.

Original languageEnglish (US)
Pages (from-to)139-155
Number of pages17
JournalHeterocycles
Volume56
Issue number1-2
StatePublished - Jan 1 2002

Fingerprint

Saponification
Hydroxylation
Cesium
Cryptococcus neoformans
Neisseria gonorrhoeae
Benzoates
Cell growth
Growth
Yeast
Sulfates
Neoplasms
Bacteria
Yeasts
Cells
Cell Line
Acids
isocarbostyril
narciclasine
pancratistatin

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

@article{c09ef60930b340b69260d547eed9bf06,
title = "Synthesis of 10b(R)-hydroxypancratistatin, 10b(S)-hydroxy-1-epipancratistatin, 10b(S)-hydroxy-1,2-diepipancratistatin and related isocarbostyrils",
abstract = "Narciclasine (2) was transformed by a series of reactions where Sharpless asymmetric hydroxylations served as the stereochemical controlling step to 10b(R)-hydroxypancratistatin (3), 10b(S)-hydroxy-1-epipancratistatin (13) and 10b(S)-hydroxy-1,2-diepipancratistatin (16). Synthesis of 10b(S)-hydroxy-1,2-diepipancratistatin (16) proceeded from α-triol (11) via cyclic sulfate (14) and inversion of C-2 with cesium benzoate followed by saponification and treatment with a catalytic amount of acid. Compared to pancratistatin (1), these structural modifications led to decreased cancer cell growth inhibition against a minipanel of human cancer cell lines. Narciclasine (2) inhibited the pathogenic yeast Cryptococcus neoformans, and modifications (4, 14 and 15) inhibited growth of the pathogenic bacterium Neisseria gonorrhoeae.",
author = "George Pettit and Noeleen Melody and Herald, {Delbert L.} and Schmidt, {Jean M.} and Robin Pettit and Jean Chapuis",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
volume = "56",
pages = "139--155",
journal = "Heterocycles",
issn = "0385-5414",
publisher = "Japan Institute of Heterocyclic Chemistry",
number = "1-2",

}

TY - JOUR

T1 - Synthesis of 10b(R)-hydroxypancratistatin, 10b(S)-hydroxy-1-epipancratistatin, 10b(S)-hydroxy-1,2-diepipancratistatin and related isocarbostyrils

AU - Pettit, George

AU - Melody, Noeleen

AU - Herald, Delbert L.

AU - Schmidt, Jean M.

AU - Pettit, Robin

AU - Chapuis, Jean

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Narciclasine (2) was transformed by a series of reactions where Sharpless asymmetric hydroxylations served as the stereochemical controlling step to 10b(R)-hydroxypancratistatin (3), 10b(S)-hydroxy-1-epipancratistatin (13) and 10b(S)-hydroxy-1,2-diepipancratistatin (16). Synthesis of 10b(S)-hydroxy-1,2-diepipancratistatin (16) proceeded from α-triol (11) via cyclic sulfate (14) and inversion of C-2 with cesium benzoate followed by saponification and treatment with a catalytic amount of acid. Compared to pancratistatin (1), these structural modifications led to decreased cancer cell growth inhibition against a minipanel of human cancer cell lines. Narciclasine (2) inhibited the pathogenic yeast Cryptococcus neoformans, and modifications (4, 14 and 15) inhibited growth of the pathogenic bacterium Neisseria gonorrhoeae.

AB - Narciclasine (2) was transformed by a series of reactions where Sharpless asymmetric hydroxylations served as the stereochemical controlling step to 10b(R)-hydroxypancratistatin (3), 10b(S)-hydroxy-1-epipancratistatin (13) and 10b(S)-hydroxy-1,2-diepipancratistatin (16). Synthesis of 10b(S)-hydroxy-1,2-diepipancratistatin (16) proceeded from α-triol (11) via cyclic sulfate (14) and inversion of C-2 with cesium benzoate followed by saponification and treatment with a catalytic amount of acid. Compared to pancratistatin (1), these structural modifications led to decreased cancer cell growth inhibition against a minipanel of human cancer cell lines. Narciclasine (2) inhibited the pathogenic yeast Cryptococcus neoformans, and modifications (4, 14 and 15) inhibited growth of the pathogenic bacterium Neisseria gonorrhoeae.

UR - http://www.scopus.com/inward/record.url?scp=0036148244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036148244&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036148244

VL - 56

SP - 139

EP - 155

JO - Heterocycles

JF - Heterocycles

SN - 0385-5414

IS - 1-2

ER -